EBUS Score Validation for Malignancy

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

September 17, 2017

Study Completion Date

September 17, 2017

Conditions
Lung NeoplasmsLung Diseases
Interventions
PROCEDURE

Endobronchial Ultrasound

Patients undergoing EBUS with TransBronchial Needle Aspiration will be invited to enroll on the day of their procedure. Once informed consent is obtained, the surgeon will assess the sonographic criteria, take pictures, and biopsy every lymph node of interest. All three elements of this assessment will need to be completed for a specimen to be included in the study. After the procedure, the operating surgeon will fill the Lymph Node Assessment questionnaire, assign an aggregate score to every lymph node specimen, and attach the pictures to the form. Pictures from every specimen will stored electronically to be reviewed and secondarily rated by a second blinded surgeon. Patient involvement in the study ends at the completion of the planned procedure.

Trial Locations (2)

L8N 4A6

St. Joseph's Healthcare Hamilton, Hamilton

M5G 2C4

Toronto General Hospital, Toronto

All Listed Sponsors
collaborator

Toronto General Hospital

OTHER

collaborator

Vancouver General Hospital

OTHER

lead

McMaster University

OTHER

NCT02793713 - EBUS Score Validation for Malignancy | Biotech Hunter | Biotech Hunter